Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.
- Soligenix Inc (NASDAQ:SNGX) announced positive preclinical data from its filovirus vaccine candidates, including thermostabilized multivalent vaccines in a single vial platform presentation.
- Data from non-human primates (NHP) demonstrated efficacy.
- Collaborators at the University of Hawaiʻi at Mānoa (UHM) describe the potent efficacy of vaccine candidates protecting against three filoviruses, Zaire ebolavirus, Sudan ebolavirus, and Marburg Marburgvirus.
- These vaccine candidates contain highly purified protein antigens combined with the novel CoVaccine HT adjuvant in monovalent (single antigen) and bivalent (two antigens) formulations.
- Efforts to formulate all three antigens and adjuvant into a thermostable single-vial vaccine platform have been shown to protect 75% of vaccinated NHPs against subsequent Sudan ebolavirus challenge.
- Price Action: SNGX shares are up 4.79% at $0.94 during the market session on the last check Wednesday.
Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!